| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Mouse,Rat |
| Host species | Rabbit |
| Applications | WB-Ce |
| Brand: | Abnova |
| Reference: | PAB0845 |
| Product name: | BBC3 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against a synthetic peptide of BBC3. |
| Gene id: | 27113 |
| Gene name: | BBC3 |
| Gene alias: | JFY1|PUMA |
| Gene description: | BCL2 binding component 3 |
| Immunogen: | A synthetic peptide (conjugated with KLH) corresponding to internal region of human BBC3. |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (1:200) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS (0.2% gelatin, 0.09% sodium azide) |
| Storage instruction: | Store at 4°C. Do not freeze. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human,Mouse,Rat |
| Applications: | WB-Ce |
| Shipping condition: | Blue Ice |
| Publications: | Treatment of chronic myeloid leukemia cells with imatinib (STI571) impairs p53 accumulation in response to DNA damage.Goldberg Z, Levav Y, Krichevsky S, Fibach E, Haupt Y. Cell Cycle. 2004 Sep;3(9):1188-95. Epub 2004 Sep 2. |